Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Salivary Gland Neoplasms, Tongue Neoplasms, Small Cell Lung Carcinoma

NCT06529081 2025-08-28

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Phase NA Recruiting

165 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06258642 2025-08-20

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Phase NA Recruiting

39 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06486428 2025-08-01

SUCCEED

Recruiting

30 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT05889546 2025-07-20

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Recruiting

30 enrolled

Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07070011 2025-07-17

Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

Recruiting

38 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT06457906 2025-07-16

SHARP

Phase 3 Recruiting

340 enrolled

CNSThoracic

Brain Neoplasms, Small Cell Lung Carcinoma

NCT04342429 2025-07-15

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Phase NA Recruiting

30 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT00301119 2025-06-26

NYULCBC

Recruiting

10,850 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07026669 2025-06-18

A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer

Recruiting

40 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT05617963 2025-06-15

DURVALUNG

Phase 2 Recruiting

100 enrolled

Thoracic

Small Cell Lung Carcinoma

Clinical Trials

PrE0510

Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment

Phase II Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment

MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients

IKF-ReWoLuTe

Relief

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

ESCALADOR

Study of Trilaciclib and Lurbinectidin

Phase 2 Study of Fingolimod in Lung Cancers

A Study of Hospital-at-Home for People Receiving Tarlatamab

Durvalumab as Consolidation for Patients LS-SCLC

Talazoparib

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

EVLC

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) With Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients From Adenocarcinoma After EGFR TKI Treatment

Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

MERLIN

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

BREATHE

ICAR

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung Cancer

7T Brain MRI Scan for Micro-brain Metastasis (microBM) Detection for Patients With Small-cell Lung Cancer (SCLC), Who Decline Prophylactic Cranial Irradiation (PCI)

LUNGEVITY

BELIEVE

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

SUCCEED

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Small Extracellular Vesicle miRNAs as Predictive Biomarkers for Immunochemotherapy Efficacy in Extensive-stage Small Cell Lung Cancer

SHARP

Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

NYULCBC

A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer

DURVALUNG